Annual Congress Stockholm 2007

Saturday, 15.09.2007
Sunday, 16.09.2007
Monday, 17.09.2007
Tuesday, 18.09.2007
Wednesday, 19.09.2007

Citations should be made in the following way: Authors. Title. Eur Respir J 2007; 30: Suppl. 51, abstract number.

Material from 2007:

4066 Abstracts
635 Slide presentations
310 Webcasts
98 Handouts
1992 e-posters
310 Multimedia files

Material from 2007: Show

New drugs for COPD

Oral Presentation
Chairs: K. F. Rabe (Leiden, The Netherlands), M. Cazzola (Rome, Italy)

Download all media

SCH 527123, a CXCR2 antagonist, inhibits ozone-induced airway neutrophilia in healthy subjects F. Kanniess, S. Khalilieh, A. Ludwig-Sengpiel, P. Stryszak, P. Soni, O. Holz, H. Magnussen (Grosshansdorf, Germany; Kenilworth, NJ, United States Of America)
REPAIR II: retinoid treatment of emphysema patients on the alpha-1-antitrypsin international registry J. Stolk, R. A. Stockley, A. Rames, O. Rutman, S. Soliman (RC Leiden, Netherlands; Birmingham, United Kingdom; Basel, Switzerland)
Inhibition of LPS-induced neutrophilic inflammation in healthy volunteers B. J. O‘Connor, B. Leaker, P. Barnes, G. Nicholson, C. Grahames, B. Larsson, A. Gaw, N. Snell, P. Newbold (London, Loughborough, United Kingdom; Lund, Sweden)
R667 retinoid agonist modulates blood glucose in COPDe patients with improved metabolic profile compared to ATRA P. Belloni, S. Aslam, L. Markovtsova, F. Bode, B. Davies (Palo Alto, CA, Nutley, NJ, United States Of America)
Aclidinium bromide, a novel muscarinic receptor antagonist combining long residence at M₃ receptors and rapid plasma clearance A. Gavalda, M. Miralpeix, I. Ramos, D. Vilella, S. Sentellas, J. Alberti, H. Ryder, J. Beleta (Barcelona, Spain)
Differentiation of bronchodilator effects of indacaterol and formoterol by FEV₁ and inspiratory capacity (IC) in patients with COPD S. Pascoe, K. M. Beeh, L. Brookman, G. Peachey, A. Hmissi, J. Beier (Horsham, United Kingdom; Wiesbaden, Germany; Basel, Switzerland)
*Superiority of the ‘triple‘ therapy of salmeterol/fluticasone propionate (SFC) and tiotropium (TIO) vs.* individual components in COPD** D. Singh, J. Brooks, G. Hagan, B. J. O‘Connor (Manchester, Greenford, London, United Kingdom)
Bronchodilator effects of aclidinium bromide, a novel long-acting anticholinergic, in COPD patients: a phase II study G. Joos, V. Schelfhout, F. Kanniess, A. Ludwig-Sengpiel, E. Garcia Gil, E. Massana Montejo (Ghent, Belgium; Grosshansdorf, Germany; Barcelona, Spain)